← Leaderboards
Laura Beth Johnson McIntire
Columbia University Health Sciences
$4,565,381
Attributed
$6,575,948
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,575,948 · 7
By mechanism
R01$4,225,323 · 2
R21$906,125 · 2
R56$810,000 · 2
K01$634,500 · 1
Top collaborators
- Vilas Menon4 shared
- Tal Nuriel4 shared
- Anna Goldshmidt Orr1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Gilbert Di Paolo$6,970,861
- Sankar Ghosh$23,629,220
- Tal Nuriel$6,961,826
- Vilas Menon$12,301,015
- Belle Chang$122,916
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainPathologyPathway InteractionsEnzymesBehavioralGenesMouse ModelGeneticReportingMemoryAnimal ModelS Disease RiskBrain TissueBrain RegionLipidsPathologicCell TypeAmyloid Beta-ProteinAbeta AccumulationPhosphatidylinositolsAmyloid Beta-Protein PrecursorPhosphoric Monoester Hydrolases
Grant awards (19)
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$626,032
R01 · FY2025 · AG · contact PI
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$374,589
R01 · FY2025 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$656,503
R01 · FY2024 · AG · contact PI
Uncovering Dementia-Related Lipid Alterations and Mechanisms in Astrocytes$466,125
R21 · FY2024 · AG
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$382,302
R01 · FY2024 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$674,456
R01 · FY2023 · AG · contact PI
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$376,879
R01 · FY2023 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$709,266
R01 · FY2022 · AG · contact PI
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$415,715
R01 · FY2022 · AG · contact PI
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$405,000
R56 · FY2021 · AG · contact PI
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease$9,581
R01 · FY2021 · AG · contact PI
Contribution of BIN1 and Synj1 to endosomal pathogenesis Alzheimer's Disease and Down Syndrome$405,000
R56 · FY2019 · AG · contact PI
The role of a novel atypical monoamine transporter in Alzheimer's disease$126,900
K01 · FY2018 · AG · contact PI
The role of a novel atypical monoamine transporter in Alzheimer's disease$126,900
K01 · FY2017 · AG · contact PI
The role of a novel atypical monoamine transporter in Alzheimer's disease$126,900
K01 · FY2016 · AG · contact PI
Screening lipid modifying enzymes to ameliorate A-beta triggered synaptic loss$200,000
R21 · FY2015 · NS · contact PI
The role of a novel atypical monoamine transporter in Alzheimer's disease$126,900
K01 · FY2015 · AG · contact PI
Screening lipid modifying enzymes to ameliorate A-beta triggered synaptic loss$240,000
R21 · FY2014 · NS · contact PI
The role of a novel atypical monoamine transporter in Alzheimer's disease$126,900
K01 · FY2014 · AG · contact PI